title: Cost effectiveness of ACE inhibitor treatment for patients with type 1 diabetes mellitus.
authors.affiliation: Battelle, Centers for Public Health Research and Evaluation, Seattle, Washington, USA.
authors.forename: Frederick B
authors.initials: FB
authors.lastname: Dong
authors.forename: Stephen W
authors.initials: SW
authors.lastname: Sorensen
authors.forename: Diane L
authors.initials: DL
authors.lastname: Manninen
authors.forename: Theodore J
authors.initials: TJ
authors.lastname: Thompson
authors.forename: Venkat
authors.initials: V
authors.lastname: Narayan
authors.forename: Carlyn E
authors.initials: CE
authors.lastname: Orians
authors.forename: Edward W
authors.initials: EW
authors.lastname: Gregg
authors.forename: Richard C
authors.initials: RC
authors.lastname: Eastman
authors.forename: Erik J
authors.initials: EJ
authors.lastname: Dasbach
authors.forename: William H
authors.initials: WH
authors.lastname: Herman
authors.forename: Jeffrey M
authors.initials: JM
authors.lastname: Newman
authors.forename: Andrew S
authors.initials: AS
authors.lastname: Narva
authors.forename: David J
authors.initials: DJ
authors.lastname: Ballard
authors.forename: Michael M
authors.initials: MM
authors.lastname: Engelgau
mesh_terms: D000328:Adult; D000367:Age Factors; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000191:economics* / Q000627:therapeutic use; D002216:Captopril / Q000191:economics* / Q000627:therapeutic use; D015331:Cohort Studies; D003362:Cost-Benefit Analysis; D048909:Diabetes Complications / Q000191:economics / Q000517:prevention & control; D003922:Diabetes Mellitus, Type 1 / Q000150:complications / Q000188:drug therapy / Q000191:economics*; D006801:Humans; D008390:Markov Chains; D018803:Models, Economic; D009010:Monte Carlo Method; D011788:Quality of Life; D016896:Treatment Outcome; D014481:United States
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D002216:Captopril